Literature DB >> 27184420

Excretion of infectious Zika virus in urine.

Fu-Chun Zhang1, Xiao-Feng Li2, Yong-Qiang Deng2, Yi-Gang Tong3, Cheng-Feng Qin4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27184420     DOI： 10.1016/S1473-3099(16)30070-6

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  52 in total

Review 1.  Animal Models of Zika Virus Infection, Pathogenesis, and Immunity.

Authors:  Thomas E Morrison; Michael S Diamond
Journal:  J Virol       Date:  2017-03-29       Impact factor: 5.103

2.  Delineating antibody recognition against Zika virus during natural infection.

Authors:  Lei Yu; Ruoke Wang; Fei Gao; Min Li; Jianying Liu; Jian Wang; Wenxin Hong; Lingzhai Zhao; Yingfen Wen; Chibiao Yin; Hua Wang; Qi Zhang; Yangyang Li; Panpan Zhou; Rudian Zhang; Yang Liu; Xiaoping Tang; Yongjun Guan; Cheng-Feng Qin; Ling Chen; Xuanling Shi; Xia Jin; Gong Cheng; Fuchun Zhang; Linqi Zhang
Journal:  JCI Insight       Date:  2017-06-15

3.  Rift Valley Fever Virus and Yellow Fever Virus in Urine: A Potential Source of Infection.

Authors:  Meng Li; Beibei Wang; Liqiang Li; Gary Wong; Yingxia Liu; Jinmin Ma; Jiandong Li; Hongzhou Lu; Mifang Liang; Ang Li; Xiuqing Zhang; Yuhai Bi; Hui Zeng
Journal:  Virol Sin       Date:  2019-03-19       Impact factor: 4.327

4.  Transfer of convalescent serum to pregnant mice prevents Zika virus infection and microcephaly in offspring.

Authors:  Shuo Wang; Shuai Hong; Yong-Qiang Deng; Qing Ye; Ling-Zhai Zhao; Fu-Chun Zhang; Cheng-Feng Qin; Zhiheng Xu
Journal:  Cell Res       Date:  2016-12-06       Impact factor: 25.617

5.  PARP12 suppresses Zika virus infection through PARP-dependent degradation of NS1 and NS3 viral proteins.

Authors:  Lili Li; Hui Zhao; Ping Liu; Chunfeng Li; Natalie Quanquin; Xue Ji; Nina Sun; Peishuang Du; Cheng-Feng Qin; Ning Lu; Genhong Cheng
Journal:  Sci Signal       Date:  2018-06-19       Impact factor: 8.192

6.  Characterization of the contemporary Zika virus in immunocompetent mice.

Authors:  Na-Na Zhang; Min Tian; Yong-Qiang Deng; Jia-Nan Hao; Hong-Jiang Wang; Xing-Yao Huang; Xiao-Feng Li; Yu-Guang Wang; Ling-Zhai Zhao; Fu-Chun Zhang; Cheng-Feng Qin
Journal:  Hum Vaccin Immunother       Date:  2016-08-15       Impact factor: 3.452

7.  Urine as Sample Type for Molecular Diagnosis of Natural Yellow Fever Virus Infections.

Authors:  Chantal B E M Reusken; Marjolein Knoester; Corine GeurtsvanKessel; Marion Koopmans; Daan G Knapen; Wouter F W Bierman; Suzan Pas
Journal:  J Clin Microbiol       Date:  2017-08-30       Impact factor: 5.948

Review 8.  Flavivirus Infections of Bats: Potential Role in Zika Virus Ecology.

Authors:  Rebekah C Kading; Tony Schountz
Journal:  Am J Trop Med Hyg       Date:  2016-09-19       Impact factor: 2.345

9.  Existing drugs as broad-spectrum and potent inhibitors for Zika virus by targeting NS2B-NS3 interaction.

Authors:  Zhong Li; Matthew Brecher; Yong-Qiang Deng; Jing Zhang; Srilatha Sakamuru; Binbin Liu; Ruili Huang; Cheri A Koetzner; Christina A Allen; Susan A Jones; Haiying Chen; Na-Na Zhang; Min Tian; Fengshan Gao; Qishan Lin; Nilesh Banavali; Jia Zhou; Nathan Boles; Menghang Xia; Laura D Kramer; Cheng-Feng Qin; Hongmin Li
Journal:  Cell Res       Date:  2017-07-07       Impact factor: 25.617

10.  AXL-Mediated Productive Infection of Human Endothelial Cells by Zika Virus.

Authors:  Shufeng Liu; Leon J DeLalio; Brant E Isakson; Tony T Wang
Journal:  Circ Res       Date:  2016-09-20       Impact factor: 17.367
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.